FDA Inspection 1168666 — Revive Rx LLC dba Revive Rx Pharmacy
The FDA completed an inspection of Revive Rx LLC dba Revive Rx Pharmacy on May 4, 2022 in Houston, TX. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- May 4, 2022
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Houston, TX (United States)